Munich is not only a beautiful city but also a place where MRI research thrives! 🧲 I am pleased to announce that our lab will host this year's Deutsche Sektion ISMRM (DACH-ISMRM) Labtour "Hyper and Hops" organized by Dr. Martin Grashei. @ISMRM @TU_Muenchen

All of this would not have been possible without the continuous support of my family for which I am deeply grateful. I am glad my children could join me for the official appointment and share this special moment with me.

🤝 I am happy to have so many supportive and like-minded colleagues and collaborators at the Department of Nuclear Medicine, at TUM and all around the globe both in industry and academia. Together with you I look forward to create the future of imaging!

🧲 I am grateful to my mentors, teachers and supervisors who have supported and guided me over many years. I learned so much from you!

🏐 First of all, I want to thank my entire team and former team members for joining me in my scientific passion and curiosity to explore the unexplored. It was and is a pleasure to work with you!

I am very glad to announce that I have been appointed as Associate Professor (W3) for Biomedical Magnetic Resonance at @TU_Muenchen.

🧲 We are on our way to the the @ISMRM taking place in Honolulu, Hawaii. Take the chance and engage with our team presenting our most recent research results according to our translational goal - from molecules to mice to men! We are looking forward to meet you! Aloha 🌺

We are looking forward to the 20th European Molecular Imaging Meeting in Bilbao organised by the European Society for Molecular Imaging. If you are interested in recent research from our group – come by and meet our presenters! #EMIM2025

As 2024 comes to an end I want to thank you on behalf of the entire team for your collaboration, support and enthusiasm. We are looking forward to continue advancing the field of magnetic resonance together and to seeing you in 2025. Happy Holidays and Merry Christmas!

for pH mapping using deep learning were developed, and the feasibility of hyperpolarized imaging of metabolism and pH within a multimodal clinical PET/MRI protocol in feline tumor patients was demonstrated. #proudPI

pHIn addition, a deeper insight into the metabolic plasticity of tumor cells and its effects on hyperpolarized 13C was gained. In vivo, a new pH probe and acquisition strategy for multiparametric hyperpolarized 13C in tumors and kidneys was presented. New analytical approaches

His work improves various facets of hyperpolarized 13C-MRI, particularly for imaging metabolism and pH. In vitro pH dependencies of relaxation time constants of hyperpolarized probes were exploited to reveal new ways for probe preparation and acquisition strategies for imaging pH

🎓 🎉 Congratulations, Martin Grashei to an excellent PhD defense! Martin took us away in his presentation on "Novel hyperpolarized 13C MRI techniques for quantification of pH and metabolism in vivo"

🏆 Congratulations to Dr. Athanasia Kaika, our most recent PhD, for winning the award for the best presentation at the 2nd Panhellenic Congress of Medical Physics which took place on October 4-6 in Athens. #MRI #MedicalPhysics

#AnalysisSensing #OnTheCover Signal Amplification by Reversible Exchange and its Translation to Hyperpolarized MRI (Knecht et al.) https://t.co/0FZ9nLtHwS @DKTK @Uniklinik_Fr @schillinglab @mpi_nat @theMOINCC @NVisionQuantum @echekmenev @waynestatechem https://t.co/Dd6cGOBaXs

It‘s basically Twitter from the old days 😉 and works fine!

Since this place here is getting more and more of a mess, you can find me on @schillinglab.bsky.social from now on as well. 💙 #BlueskySocial

Partners involved in the QuE-MRT project: @TU_Muenchen , @NVisionQuantum, @Qruise_ai , RAPID Biomedical GmbH, @SiemensHealth, Universität Ulm, Universitätsklinikum Ulm, @Uniklinik_Fr

👉 In the QuE-MRT project, researchers, doctors, industrial partners and developers from the fields of medicine, physics, chemistry and engineering are working closely together to optimize the quantum hyperpolarizer. The team is also planning the first clinical studies in 2026.

@NVisionQuantum has presented the first product developed in the project - the preclinical quantum hyperpolarizer called “Polaris”, used in the research laboratories of the Department of Nuclear Medicine. Spectacular metabolic images were already taken in the first few days.